XML 34 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes (Details Narrative)
3 Months Ended
Jun. 30, 2016
USD ($)
Income Tax Disclosure [Abstract]  
Deferred tax asset $ 12,649,153
Net operating loss carry forwards 37,203,393
Amount of NOL acuired in reverse aquisition fo BMSG 38,616
Amount of NOL attributable to Bio-Matrix Scientific Group, Inc. $ 37,164,777
Federal Corporate income tax Rate 34.00%